Hypertrophic pachymeningitis associated with cerebral spinal fluid hypovolemia as initial presentation of systemic lupus erythematous

We report a case of a 61-year-old man with thickening of the dura mater associated with the presence of subdural collections as a consequence of cerebral spinal fluid hypovolemia (CSFH) and hypertrophic pachymeningitis (HP) as presentation of systemic lupus erythematous (SLE). The patient complained about fatigue, musculoskeletal pain, headache and skin lesions. In the laboratory tests minimal normocytic anemia, mild leukopenia, polyclonal hypergammaglobulinemia and antinuclear antibodies (ANA), anti-double-stranded DNA antibodies (dsDNA), antibodies against extractable nuclear antigens (ENA) type SSA-Ro, anti-Smith antigen antibodies (anti-Sm) and anti-ribonucleoprotein antibodies (anti-RNP) were detected. Cranial magnetic resonance imaging (MRI), with and without gadolinium enhancement, revealed generalized thickening of the dura mater more severe at the right parieto-occipital lobes with the presence of subdural collections. The patient was diagnosed with SLE associated both with CSFH and HP. A conservative treatment with prednisone 60 mg daily, mycophenolate mofetil (MMF) 1 g daily and hydroxychloroquine 200 mg twice a day was started with significant clinical and radiological improvement (almost complete resolution of the subdural collections and clear decrease of meningeal thickness). The authors emphasize that HP associated with CSFH in the context of SLE is a rare entity, which makes this case unique.

[1]  P. Goadsby,et al.  Update on intracranial hypertension and hypotension. , 2013, Current opinion in neurology.

[2]  W. Becker,et al.  Spontaneous Intracranial Hypotension: Recommendations for Management , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[3]  S. Kaname,et al.  [Case report: a case of medial longitudinal fasciculus syndrome and hypertrophic pachymeningitis in an elderly-woman with systemic lupus erythematosus]. , 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[4]  Á. Blanco-Molina,et al.  Un nuevo abordaje terapéutico: remisión de las enfermedades fibrosantes tras la administración de bolos de metilprednisolona a altas dosis , 2012 .

[5]  Á. Blanco‐Molina,et al.  [A novel therapeutical approach: remission of fibrosing diseases after intravenous high-dose bolus of methylprednisolone]. , 2012, Revista clínica española (Ed. impresa).

[6]  M. Hadjivassiliou,et al.  Idiopathic hypertrophic pachymeningitis responsive to mycophenolate. , 2011, Acta neurologica Belgica.

[7]  L. Defebvre,et al.  Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature , 2007, Rheumatology International.

[8]  J. Smirniotopoulos,et al.  Patterns of contrast enhancement in the brain and meninges. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[9]  Junichi Ogawa,et al.  全身性エリテマトーデスに肥厚性硬膜炎を合併し, 低髄圧症候群様の頭痛・難聴を呈した1例 , 2007 .

[10]  H. Hagiyama,et al.  [A case report of hypertrophic pachymeningitis associated with systemic lupus erythematosus, showing a headache and hearing loss resembling intracranial hypotension]. , 2007, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[11]  M. Kupersmith,et al.  Idiopathic hypertrophic pachymeningitis , 2004, Neurology.

[12]  M. Otsuka,et al.  [Leptomeningeal abnormality on Gd-DTPA enhanced MRI in a case of SLE presenting diffuse organic brain syndrome]. , 1993, Rinsho shinkeigaku = Clinical neurology.